The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
50 jobs Number of planned job creations
Announcement Date
30 April 2019
Employment effect (start)
Foreseen end date
31 May 2021
Description
Fujifilm Diosynth Biotechnologies (FDB) has announced plans to create 50 new jobs as part of its expansion in North East England. The company which produces biological cultures for the pharmaceutical industry will locate its existing 250 staff in the new facility as well as adding the new jobs. The development of the new Biocampus will be partly supported by a grant of GBP 3.625 million from the Tees Valley Combined Authority. This local development funding will contribute approximately one quarter of the cost of the new facility. It is expected that the new jobs will be filled over a two-year period.
Eurofound (2019), Fujifilm Diosynth Biotechnologies, Business expansion in United Kingdom, factsheet number 97732, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/97732.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
